Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05651945 · ClinicalTrials.gov registry record · NA
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
A NA study of Stroke and Cerebrovascular Accident, sponsored by Hackensack Meridian Health.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05651945: Recruiting NA study of Stroke and Cerebrovascular Accident, sponsored by Hackensack Meridian Health.
NCT05651945 is a NA study of Stroke and Cerebrovascular Accident that is actively recruiting participants, run by Hackensack Meridian Health. The registered enrollment target is 150 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05651945, a NA study of Stroke and Cerebrovascular Accident, is actively recruiting participants, sponsored by Hackensack Meridian Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the effectiveness of the cardiac rehabilitation program for stroke patients. The study will examine if patients with stroke, who receive cardiac rehabilitation in addition to their standard of care treatments, demonstrate improved recovery of function. It will also examine if these patients have reduced hospital readmission, reduced rate of recurrent stroke, and mortality.
Primary Outcome
Mean change in 6MWT score from baseline (30 days post-stroke) to 120 days post-stroke.
Conditions Studied
Interventions
- OTHER Cardiac rehabilitation program
Study Locations (1)
New Jersey
- Hackensack Meridian Health - JFK Johnson Rehabilitation Institute - Edison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-01-20 |
| Est. Completion | 2031-01-20 |
| Phase | NA |
What NCT05651945 shows while recruiting
NCT05651945 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Cardiac rehabilitation program is the first listed.
NCT05651945 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05651945 about?
NCT05651945 is a clinical study titled "Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)". This study examines the effectiveness of the cardiac rehabilitation program for stroke patients. The study will examine if patients with stroke, who receive cardiac rehabilitation in addition to their standard of care treatments, demonstrate improved recovery of function. It will also examine if the...
What is the current status of trial NCT05651945?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-01-20. Estimated completion is 2031-01-20.
What conditions does trial NCT05651945 study?
This clinical trial studies the following conditions: Stroke, Cerebrovascular Accident.
What interventions are being tested in trial NCT05651945?
The interventions under investigation include: Cardiac rehabilitation program (OTHER).
Who is sponsoring clinical trial NCT05651945?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05651945 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05651945's enrollment target sits among peer trials
150 105th of 454 higher than 346 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI